Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Arap, W' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Pasqualini, R; McDonald, DM; Arap, W
      Vascular targeting and antigen presentation

      NATURE IMMUNOLOGY
    2. Grifman, M; Trepel, M; Speece, P; Gilbert, LB; Arap, W; Pasqualini, R; Weitzman, MD
      Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

      MOLECULAR THERAPY
    3. Kolonin, M; Pasqualini, R; Arap, W
      Molecular addresses in blood vessels as targets for therapy

      CURRENT OPINION IN CHEMICAL BIOLOGY
    4. Giordano, RJ; Cardo-Vila, M; Lahdenranta, J; Pasqualini, R; Arap, W
      Biopanning and rapid analysis of selective interactive ligands

      NATURE MEDICINE
    5. Lahdenranta, J; Pasqualini, R; Schlingemann, RO; Hagedorn, M; Stallcup, WB; Bucana, CD; Sidman, RL; Arap, W
      An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    6. Trepel, M; Arap, W; Pasqualini, R
      Modulation of the immune response by systemic targeting of antigens to lymph nodes

      CANCER RESEARCH
    7. Bhagwat, SV; Lahdenranta, J; Giordano, R; Arap, W; Pasqualini, R; Shapiro, LH
      CD13/APN is activated by angiogenic signals and is essential for capillarytube formation

      BLOOD
    8. Trepel, M; Arap, W; Pasqualini, R
      Exploring vascular heterogeneity for gene therapy targeting

      GENE THERAPY
    9. Tellier, MC; Greco, G; Klotman, M; Mosoian, A; Cara, A; Arap, W; Ruoslahti, E; Pasqualini, R; Schnapp, LM
      Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4(+) T lymphocytes

      JOURNAL OF IMMUNOLOGY
    10. Pasqualini, R; Koivunen, E; Kain, R; Lahdenranta, J; Sakamoto, M; Stryhn, A; Ashmun, RA; Shapiro, LH; Arap, W; Ruoslahti, E
      Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis

      CANCER RESEARCH
    11. Koivunen, E; Arap, W; Valtanen, H; Rainisalo, A; Medina, OP; Heikkila, P; Kantor, C; Gahmberg, CG; Salo, T; Konttinen, YT; Sorsa, T; Ruoslahti, E; Pasqualini, R
      Tumor targeting with a selective gelatinase inhibitor

      NATURE BIOTECHNOLOGY
    12. Ellerby, HM; Arap, W; Ellerby, LM; Kain, R; Andrusiak, R; Del Rio, G; Krajewski, S; Lombardo, CR; Rao, R; Ruoslahti, E; Bredesen, DE; Pasqualini, R
      Anti-cancer activity of targeted pro-apoptotic peptides

      NATURE MEDICINE
    13. Koivunen, E; Arap, W; Rajotte, D; Lahdenranta, J; Pasqualini, R
      Identification of receptor ligands with phage display peptide libraries

      JOURNAL OF NUCLEAR MEDICINE
    14. Burg, MA; Pasqualini, R; Arap, W; Ruoslahti, E; Stallcup, WB
      NG2 proteoglycan-binding peptides target tumor neovasculature

      CANCER RESEARCH
    15. Koivunen, E; Restel, BH; Rajotte, D; Lahdenranta, J; Hagedorn, M; Arap, W; Pasqualini, R
      Integrin-binding peptides derived from phage display libraries

      INTEGRIN PROTOCOLS
    16. Schneller, M; Arap, W; Pasqualini, R
      Immunoblotting of integrins

      INTEGRIN PROTOCOLS
    17. Arap, W; Huang, HJS
      Expression of integrin transcripts in human cancer cells

      INTEGRIN PROTOCOLS
    18. ARAP W; PASQUALINI R; RUOSLAHTI E
      CANCER-TREATMENT BY TARGETED DRUG-DELIVERY TO TUMOR VASCULATURE IN A MOUSE MODEL

      Science
    19. RAJOTTE D; ARAP W; HAGEDORN M; KOIVUNEN E; PASQUALINI R; RUOSLAHTI E
      MOLECULAR HETEROGENEITY OF THE VASCULAR ENDOTHELIUM REVEALED BY IN-VIVO PHAGE DISPLAY

      The Journal of clinical investigation
    20. ARAP W; KNUDSEN E; SEWELL DA; SIDRANSKY D; WANG JYJ; HUANG HJS; CAVENEE WK
      FUNCTIONAL-ANALYSIS OF WILD-TYPE AND MALIGNANT GLIOMA DERIVED CDKN2A-BETA ALLELES - EVIDENCE FOR AN RB-INDEPENDENT GROWTH SUPPRESSIVE PATHWAY

      Oncogene
    21. ARAP W; KNUDSEN ES; WANG JYJ; CAVENEE WK; HUANG HJS
      POINT MUTATIONS CAN INACTIVATE IN-VITRO AND IN-VIVO ACTIVITIES OF P16(INK4A) CDKN2A IN HUMAN GLIOMA/

      Oncogene
    22. COSTELLO JF; PLASS C; ARAP W; CHAPMAN VM; HELD WA; BERGER MS; HUANG HJS; CAVENEE WK
      CYCLIN-DEPENDENT KINASE-6 (CDK6) AMPLIFICATION IN HUMAN GLIOMAS IDENTIFIED USING 2-DIMENSIONAL SEPARATION OF GENOMIC DNA

      Cancer research
    23. CHENG SY; HUANG HJS; NAGANE M; JI XD; WANG DG; SHIH CCY; ARAP W; HUANG CM; CAVENEE WK
      SUPPRESSION OF GLIOBLASTOMA ANGIOGENICITY AND TUMORIGENICITY BY INHIBITION OF ENDOGENOUS EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR

      Proceedings of the National Academy of Sciences of the United Statesof America
    24. NISHIKAWA R; FURNARI FB; LIN H; ARAP W; BERGER MS; CAVENEE WK; HUANG HJS
      LOSS OF P16(INK4) EXPRESSION IS FREQUENT IN HIGH-GRADE GLIOMAS

      Cancer research
    25. ARAP W; NISHIKAWA R; FURNARI FB; CAVENEE WK; HUANG HJS
      REPLACEMENT OF THE P16 CDKN2 GENE SUPPRESSES HUMAN GLIOMA CELL-GROWTH/

      Cancer research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 13:12:41